Novartis, Super Bowl and Wanda Sykes

Novartis will make its Super Bowl debut with a breast cancer awareness ad
Pharmaceutical company Novartis will make its Super Bowl debut with a 60-second spot highlighting breast cancer awareness.
Novartis is bringing breast cancer awareness to Super Bowl LIX with the help of Hailee Steinfeld and Wanda Sykes
Novartis is airing its first-ever Super Bowl ad to raise awareness about breast cancer and promote regular screenings. The campaign highlights the imp
Novartis taps Hailee Steinfeld, Wanda Sykes for breast cancer Super Bowl ad
In addition to the partnership with Steinfeld and Sykes, Novartis is collaborating on awareness efforts and advocacy events with organizations like the Susan G. Komen, Living Beyond Breast Cancer, TOUCH (The Black Breast Cancer Alliance) and Breastcancer.org.
Sykes, Steinfeld, Breasts Star In Novartis Super Bowl Debut
"An attention-grabbing call to prioritize breast health," includes a focus on cheerleaders' and Hailee Steinfeld's breasts, with cut-in to cancer survivor Wanda Sykes.
“Honored and so proud”: Hailey Steinfeld revealed her participation in the Super Bowl, by collaborating with Novartis for the promotion of breast health
The Buffalo Bills lost to the Kansas City Chiefs in the AFC Championship Game. Hailee Steinfeld, fiancée of Bills quarterback Josh Allen, announced her involvement in a Super Bowl commercial promoting breast cancer awareness.
Hailee Steinfeld's 'bucket list' Super Bowl commercial raises breast cancer awareness
Hailee Steinfeld is teaming up with Novartis to raise awareness about breast cancer with an empowering Super Bowl 59 commercial.
Hailee Steinfeld Encourages Women to 'Give Breasts the Attention They Deserve' in Super Bowl Ad: (Exclusive)
Hailee Steinfeld and Wanda Sykes are partnering with Novartis to encourage women to understand their breast cancer risk and get early screenings in a new ad that will air during the Super Bowl on Sunday,
Hosted on MSN17h
Novartis to Report Q4 Earnings: What's in the Offing?
Novartis AG NVS, a Swiss pharma giant, is scheduled to report fourth-quarter 2024 and full-year results on Jan. 31, 2025. The ...
FiercePharma1d
Novartis' first Super Bowl ad aims to 'create a movement' with breast cancer awareness blitz
To direct more attention toward the importance of regular breast cancer screenings, Novartis is taking to one of television’s ...
IPWatchdog1h
An Enablement Defense is Disabled by the Federal Circuit
In Novartis Pharms. Corp. v. Torrent Pharma Inc., the U. S. Court of Appeals for the Federal Circuit shut down efforts to market a generic version of the heart disease drug ENTRESTO which is sold ...
BioPharma Dive20h
Rival radiopharma drug to Novartis’ Lutathera succeeds in trial, ITM says
ITM's lutetium-containing therapy extended progression-free survival versus everolimus in patients with a specific kind of ...
US appeals court reinstates pause on generic version of Novartis' Entresto
Novartis won an order from a U.S. appeals court in Washington on Thursday temporarily blocking drugmaker MSN Pharmaceuticals ...
Early detection is a game changer: Novartis makes bold play to prioritize breast health and inspire a new wave of breast cancer screenings
Novartis, a global leader in breast cancer care, today announced the launch of the "Your Attention, Please" campaign, which ...
Novartis India Standalone December 2024 Net Sales at Rs 93.00 crore, up 10.01% Y-o-Y
Quarterly Net Profit at Rs. 25.45 crore in December 2024 down 4.22% from Rs. 26.57 crore in December 2023. EBITDA stands at Rs. 36.18 crore in December 2024 down 13.3% from Rs. 41.73 crore in December ...
Novartis wins temporary pause to Entresto generic launch in US
A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' ...